Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2000;46:144-146; doi:10.1136/gut.46.2.144
Copyright © 2000 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2000;46:144-146 ( February )

Leading article

Proton pump inhibitors for Barrett's oesophagus

The first 150 words of the full text of this article appear below.

    Introduction

Barrett's oesophagus is a metaplastic condition in which the normal squamous oesophageal epithelium is replaced by specialised intestinal metaplasia.1 Barrett's oesophagus occurs in about 10% of patients with gastro-oesophageal reflux disease (GORD) and predisposes to dysplasia and adenocarcinoma.2 The incidence of oesophageal and gastric cardia adenocarcinoma is rapidly increasing by a rate exceeding that of any other cancer.3 4 Over the past decade, acid suppression with proton pump inhibitors (PPIs) has become the mainstay of treatment of patients with Barrett's oesophagus. This article reviews the specific end points of such treatment.


    Control of reflux symptoms

Concomitant symptomatic GORD is common in patients with Barrett's oesophagus and manifests as heartburn, regurgitation, dysphagia, or chest pain.5 Numerous trials have documented that PPIs provide superior relief of heartburn compared with H2-receptor antagonists (H2RAs). In a recent meta-analysis of GORD studies of patients with endoscopically proved erosive oesophagitis, PPIs, irrespective of dose or duration of treatment, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Jenkins, G. J.S., D'Souza, F. R., Suzen, S. H., Eltahir, Z. S., James, S. A., Parry, J. M., Griffiths, P. A., Baxter, J. N. (2007). Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett's oesophagus. Carcinogenesis 28: 136-142 [Abstract] [Full Text]  
  • Sarela, A. I., Hick, D. G., Verbeke, C. S., Casey, J. F., Guillou, P. J., Clark, G. W. B. (2004). Persistent Acid and Bile Reflux in Asymptomatic Patients With Barrett Esophagus Receiving Proton Pump Inhibitor Therapy. Arch Surg 139: 547-551 [Abstract] [Full Text]  
  • Basu, K K, de Caestecker, J S (2002). Surveillance in Barrett's oesophagus: a personal view. Postgrad. Med. J. 78: 263-268 [Abstract] [Full Text]  
  • Eksteen, J., Latchford, A, Thomas, S., Jankowski, J. (2001). Commentary: Regional variations in oesophageal and gastric cardia cancers--implications and practice. Int J Epidemiol 30: 1425-1427 [Full Text]  
  • Dixon, M F, Neville, P M, Mapstone, N P, Moayyedi, P, Axon, A T R (2001). Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?. Gut 49: 359-363 [Abstract] [Full Text]  
  • Chen, X., Yang, C. S. (2001). Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22: 1119-1129 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs